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Abstract 
Objective:  In  this  study  we  verified  the  epidemiology of  HBV  infection  among  normal  population  and 
healthcare workers (HCWs) in Baghdad by analyzing the prevalence of specific viral markers (anti-HBs, anti- 
HBc and HBsAg). Method: A total of 797 serum specimens (588-normal population, 209-HCWs) were tested 
using ELISA technique and positive HBsAg specimens were confirmed by VIDAS technique. Results:  In 
normal population group, the HBsAg, anti-HBs and anti-HBc Total were 1.02%, 10.54%, 5.44%, respectively. 
The HBsAg result was significantly lower (P< 0.05) than previous studies were done in Iraq. Significant 
correlation (P < 0.05) in prevalence of HBsAg was found between age groups and males had higher positive 
HBsAg marker than females (P < 0.05). The prevalence of anti-HBs was insignificant (P＞0.05) between age 
groups but significant importance (P < 0.05) was recorded between both sexes. Highly significant (P＜0.01) was 
recorded between ages groups regarding to anti-HBc Total marker but insignificantly (P＞0.05) between both 
sexes  were  noticed.  In  HCWs  group  the  HBsAg,  anti-HBs,  anti-HBc  Total  were  0.96%,  26.7%,  1.44% 
respectively  and  the  prevalence  of  HBsAg  was  significantly  less  (P  <  0.05)  than  previous  studies.  The 
comparison between normal population and HCWs groups showed significant correlation (P < 0.05) related to 
HBsAg and highly significant correlation (P＜0.01) regarding anti-HBs and anti-HBc Total. The HBsAg and 
anti-HBs among HCWs was significantly increased (P＜0.05) with advancing ages, whereas no such variation 
was observed between both sexes. The HBsAg was high among those with poor health education but it was with 
significantly importance (P< 0.05) among different occupational types as well as among vaccinated, incomplete 




and those who had 
3
rd 
doses showed significant correlation between number of vaccinated individuals and prevalence of anti-HBs. 
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Introduction 
           Hepatitis B virus (HBV) is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular 
carcinoma, accounting at least 2 billion people have been infected with HBV worldwide with an estimated 400 
million being chronic carriers of the virus (WHO, 2012). HBV most prevalent in Asia and Sub-Saharan Africa, 
in the Amazon Basin, and less prevalent in the United States, Northern Europe, Australia and parts of 
South America; the Middle East, some countries of Eastern Europe and the Mediterranean Basin were 
considered areas of intermediate endemicity (Franco, et al., 2012). Old figure of seroprevalence of HBV in Iraq 
indicate that the carrier rate was (3-4.5%) among normal population and 2-3% among healthy blood donors 
and according to these results; Iraq was categorized under the intermediate endemic countries (Andre, 2000; 
WHO, 2006). Lower carrier rates (1-2%) was recorded among Iraqi blood donors (Omer, 2004), another study 
was reported low rate of HBsAg (1.6%) in Iraq, whereas in Baghdad the HBsAg rate was 1.2% (Omer and Al-
Salmani, 2007). The present  study  recorded  the  seroprevalence  of  HBsAg,  anti-HBs  Abs  and  anti-HBc  
Total  among  normal population were 1.02 %, 10.54 % and 5.44 % respectively, and this finding of HBsAg was 
lower than all that previously reported in Iraq with statistically significant importance (P = 0.036). 
 
In the health care setting, HBV transmission may occur via several routes, but the most frequent route 
leading to establishment of HBV infection is through needle stick injury, invasive surgical procedures are 
another route of HBV transmission (Bhat, et al., 2012). In Iraq few reports exist on the prevalence of HBV 
among HCWs (Omer et al. 1984; Al-Mashhadani, 1998) and all previous studies demonstrated a high 
seroprevalence of HBsAg among HCWs ranged from (5 -1%). Our study was recorded the seroprevalence of 
HBsAg, anti- HBs and anti- HBc Total among HCWs was 0.96 %, 26.79 % and 1.44 % respectively, which was 
significantly less than previous studies were done in Iraq. Vaccination is considered the most effective measure 
to reduce the incidence of HBV infection (Boccalini, 2013); Iraq was introducing a program of universal 
vaccination against HBV in the middle of 1990s. In this study we verified the impact of universal immunization 
on the epidemiology of HBV infection by analyzing the prevalence of specific viral markers (anti-HBs, anti-HBc 
and HBsAg) among normal populations and HCWs as a risk group chosen from various hospitals and health 
center in Baghdad. 
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2. Materials and methods 
2.1 Study design and setting 
This study was carried out at the Viral Hepatitis Reference Laboratory /Central Public Health Laboratories from 
October 2014 to July 2015, to determine the seroprevalence of HBV infection among normal population and 
HCWs in Baghdad. 
2.1.1 Normal Population Group 
This group was with the following criteria; healthy individuals from different age and sex with no signs of HBV 
infection. They were showed neither clinical symptoms nor abnormalities via biochemical laboratory tests, all 
individuals were residents in Baghdad. A total of 588 serum specimens from individuals with age of both sexes 
ranged from one day to 71 years old were collected. This group consisted of 366 (62.24 %) male and 222 
(37.75 %) female, with male to female ratio as 1.6-1. 
2.1.2 HCWs Group 
A total of 209 serum specimens were collected from apparently healthy HCWs selected from different hospitals 
in Baghdad with age ranged (20 – 60) years old. This group consisted of 112 (53.58 %) male and 97 (46.41 %) 
female, with male to female ratio 1.15-1. They were submitted for historical questionnaire about a previous 
vaccination with HBV vaccine and number of doses that had been taken, either with or without vaccine booster 
dose. 
 
2.2 Sample collection 
Blood specimens were collected in randomly way, recording name, age, sex, code and date of collection. 
Specimens were collected from each individual via vein-puncture in 5-ml red-top vacutainer tube (Becton 
Dickinson, NJ, USA) and allowed the blood clot naturally at room temperature (RT). Serum specimens were 
separated by centrifugation at 3000 g for 5 min. Then divided into aliquots 250µl (4 tubes for each sample) and 
stored at -20ºC until use. Each part of sera was used once to avoid repeated thawing and freezing. All materials 
(i.e. reagents and sera) were allowed to stand at RT before use. 
 
2.3 Biochemical Assays 
Liver function tests, including alanine aminotransferase test (ALT), (normal range, up to 13 u/l) and total serum 
bilirubin (TSB), (normal range, less than 1mg/dl) levels (Young, 1997) were done for all individuals from both 
groups at initial examination using commercially available ELISA kits (Randox, UK). 
 
2.4 Screening for HBV serological Markers 
Serum specimens were screened for HBsAg, anti-HBs and anti-HBc Total using commercial available ELISA 
Kits (Bioelisa HBsAg, Bioelisa anti-HBs and anti-HBc Biokit, Spain). The positive specimens for HBsAg were 
confirmed using “Vitec Immune Diagnostic Assay System” (VIDAS) and (Hepanostika HBsAg Uni-Form II 
confirmatory; Bio Merieux, France) Kit. All criteria provided by the producers for the qualitative evaluation of 
antibodies and antigen detection, were applied according to specific instruction manual. 
 
2.5 Statistical analysis 
Data were translated into codes using a designed table sheet and then converted to a computerized database. 
Statistical analyses were done by using SPSS version 15, under windows 
XP 
and Mini. Tab programmes; the data 
were given as means ± SD of numbers and percentage. And significance differences between the means of 
certain continuous outcome were assessed by ANOVA table (F-test) or t-test. Chi-square test (X
2
) was also used 
to assess significant differences between frequencies. 
 
 
 3. Results and discussion  
 3.1 Seroprevalence of HBV markers among normal population 
The seroprevalence of HBsAg, anti-HBs and anti-HBc Total was 1.02 %, 10.54 % and 5.44 % respectively (Fig. 
1). The results of HBsAg in present study on the one hand, in line with the results that were recorded from 2002 
till 2008 by Iraq / CDC in which the prevalence of HBsAg in Baghdad was 1.2% among normal population 
(Omer and Al- Salmani, 2007). 
Indeed, the results of Iraq /CDC were based on the prevalence of HBsAg among blood donors who were mostly 
urban middle class young males, because of the trend in blood donation in our country, while the present study 
included different age groups and both sex. On the other hand, the present study results of HBsAg was lower than 
all that previously reported in Iraq (Al-Azawi and kadori, 1984; Al-Mashhadani, 1998) with significant 
statistically importance (P = 0.036). The low seroprevalence of both anti-HBs and anti-HBc Total in the present 
study consistent with previous work was done in Iraq (Omer and Al-Salmani 2007), and these findings of both 
markers indicates low coverage rates of vaccination and low past infections were acquired among normal 
population (Bonanni, et al., 2003; Jawetz et al., 2007).   
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Fig. 1. Seroprevalence of HBsAg, anti-HBs & anti-HBc Total among normal population group 
 
      Then, we compared the seroprevalence of HBsAg in normal population according to the age groups. Table (1) 
shows, the age groups ranged from one day to 74 years with a mean of age 22.77 ± 19.6. The highest rate of 
HBsAg (2.70%) was located in the age group (51 years and above) with statistically significant (P< 0.05) followed 
by the age group (less than one year) it was (2%) with insignificant correlation (P >0.05) and it was decreased in 
age groups (1-5, 16-20 and 31-40) years old also with insignificant correlation (P > 0.05), while this marker did not 
score at all in other age groups. 
 
 
Table (1): Seroprevalence of HBsAg according to the age among normal population 
No. Age group   
(year) 
Mean ± SD No. tested HBsAg      
positive No 
     % 
1 < 1 5.5 ± 3.93 
 
50 1 2٭ 
2 1- 5 3.2 ± 1.27 56 1 1.78٭ 
3 6- 10 7.9 ± 1.47 51 0 0 
4 11- 15 13.02 ± 1.5 50 0 0 
5 16- 20 18.2 ± 1.45 73 1 1.36٭ 
6 21- 30 25.5 ± 3.11 83 0 0 
7 31- 40 35 ± 2.8 80 1 1.25٭ 
8 41- 50 45 ± 3.7 71 0 0 
9 ≥ 51 57 ± 4.53 74 2 2.70٭٭ 
    Total   588 6 1.02 




     However, the prevalence of HBsAg marker among infants and children may be related to perinatal transmission 
from mother to her baby (Ye et al., 2006; Schillie, et al., 2015). Notably, those babies might have not enrolled in 
the National Immunization Program. While the prevalence of HBsAg among adult age groups may return to blood, 
blood products transfusion or other horizontal risk factors such as sexual transmission similar to many developing 
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         Figure 2 shows, the seroprevalence of HBV serological markers in normal population according to the sex. 
Out of 366 males were tested, the HBsAg, anti-HBc Total and anti-HBs rates was 1.09 %, 5.46 %, and 
11.20 % respectively, whereas out of 222 females were tested, it was 0.90 %, 5.40 % 9.45 % respectively. This 
distribution showed the males had highly positive HBsAg marker than females with statistically significant 




Fig. 2. The distribution of HBV serological markers among normal population group according to sex 
 
 
The differences between both sexes could be explained on the basis that males may have a greater 
chance to come in contact with risk of horizontal transmission factors of HBV infection than females, or alcohol 
intake being common in males that may enhance the liver damage caused by HBV infection (Ugwu, et al., 2008). 
This  observation  is  in  consistent  with  earlier  studies  were  done  in  Iraq  (Sabri,  2003).  Regarding the 
seroprevalence of anti-HBc Total, insignificant correlation was recorded in this study between male and female 
(P> 0.05). Furthermore, those individuals who were positive to the anti-HBs and anti-HBc Total together, that 
indicates they acquired past infection with immunity. On the contrary, the remaining individuals in both groups 
who had anti-HBs alone, that indicate those individuals were enrolled in the National Immunization Program 
(WHO, 2012). Such of this result, however, point out fallen seroprevalence of HBV infection among normal 
population in Baghdad. Since the development of a vaccine to prevent acute HBV infection in the early 1980s, 
the incidence of acute HBV infection in the general population of the United States has sharply fallen (Lewis et 
al., 2015). The CDC estimates that the incidence of new HBV infections had fallen 5-fold between 1980 and 
2010 (USA, CDC, 2014). 
 
3.2 Seroprevalence of HBV markers among HCWs 
      Figure 3 reveals the HCWs that were screened for the detection of HBsAg, anti-HBs and anti-HBc Total, 
with results of 0.96 %, 26.79 % and 1.44 % respectively. This result of HBsAg compatible with many reports 
around the world (Schiff, 2004; Djeriri et al. 2008), but it is incompatible with all previously published in Iraq 
(Al-Alwan et al., 1986; Al-Mashhadani, 1998). The highly differences and improving in the results in present 
study compared with previous results may be due to the introduction of vaccination program among HCWs, as 
well as, may be related to the increase awareness and health educations.  
 
       In comparison between normal population and  HCWs groups, Figure 3 shows the high prevalence rate of 
HBsAg (1.02%) among normal population compared with rate of (0.96%) among HCWs with statistically 
significant (P< 0.05), this fallen in HBsAg results among HCWs may be due to the “National Hepatitis Control 
Program”  especially  vaccination,  increasing  awareness  and  health  education,  increasing  use  of  barrier 









precautions and personal protective devices as well as improvement of general hygiene condition in the hospital    
setting by availability of disposable syringes and other medical equipments as possible, in addition to using 






Fig. 3. Seroprevalence of HBV markers among HCWs and normal population 
 
 
            It should be noted, although HBV infection was higher among HCWs than that of the normal population 
before development of the HBV vaccine, this situation has been reversed, with many HCWs having previously 
received the vaccine (Mahoney, et al., 1997; Bhat et al., 2012). Also the anti-HBc Total rate was a greater 
proportion among normal population group (5.44%) compared with HCWs group (1.44%) which displayed highly 
significant importance (P < 0.01), indicated high prevalence of HBV infection among normal population than 
HCWs group (Boccalini et al., 2013; Lewis et al., 2015). This finding may due to improvement of vaccination 
program among HCWs group than normal population group. In regard  to  anti-HBs,  the  higher  rate (26.79%)  
was  observed  among  HCWs  group  compared  with  this  was recorded among normal population group 
(10.54%) with statistically significant correlation (P<0.05), the high variation may due to high differences in 
vaccination coverage between two populations. 
 
 
Table (2): seroprevalence of HBsAg and anti-HBs among HCWs according to their occupation 
Occupation No. tested No. HBsAg  
positive 
%HBsAg      
positive 




Physician 39 0 ------ 22 56.4٭ 
Lab. Staff 62 0 ------ 11 17.7٭ 
Paramedical 
staff 
36 0 ------ 9 25.0٭ 
Nurses 34 0 ------ 9 26.4٭ 
Workers
٭
٭  38 2 0.006٭ 5 13.1٭ 
Total 209 2 ------ 56 26.7 
٭ statistically significant (P < 0.05), ٭٭Supporting nonprofessional staffs, which clean the wards 
                 and instruments and food handlers 
 
 
   Table (2) illustrates the seroprevalence of HBsAg marker among HCWs according to their occupation. The     
HBsAg marker was recorded only among “workers” group with statistically significant importance (P < 0.05), 
whereas no evidence of HBsAg marker was found in the other groups. 
 
 









           This result is incompatible with previous studies were done in Baghdad, (Al-Mashhadani, 1998). The 
differences between the present study result and previous studies results may be due to improvement in hygiene 
situation among various HCWs groups due to the introduction of control and vaccination program, increased 
awareness and health education, but it may be reflect a poorly improvement among workers group; because 
majority of them were non-professional staff, older age groups, poorly health educated and from low socio-
economic status, and most of them were working in high intensity areas (clean the wards and instruments) with 
direct contact with wastes and patient’s blood and other fluids. 
             Table (2) also illustrates the distribution of anti-HBs serological marker among HCWs according to 
their occupation. The total prevalence among all groups was (26.7%) and the statistical analysis showed 
significant correlation (P < 0.05) among all groups compared with total population percentage. The highest rate 
(56.4%) was found among physician group followed by nurses, paramedical staff and laboratory staff groups 
with rate of 26.4 %, 25.0 % and 17.7 % respectively. Whereas the lowest rate (13.1%) were located in workers 
group, this result in a concordance with previous study in Iraq (Al-Mashhadani, 1998) and it is may be related to 
low healthy education among workers group compared with physicians group. 
 
 
The seroprevalence of HBsAg marker among HCWs according to the age is shown in table (3), the 
highest rate (4.76%) was found in the age group 51- 60 years old followed by age group 41-50 year old with rate 
of (2.22%) with significant importance (P< 0.05) between above age groups compared with total population 
percentage, whereas no evidence of HBsAg marker was found in the younger age groups (20-30, 31-40) years 
old. These results are not consistent with previous study in Baghdad (Al-Mashhadani, 1998). But these results 
coincide with other study; the increased prevalence of HBsAg marker with advancing age among HCWs may be 
due to non enrollment those individuals in vaccination program in their life. Or those individuals with anti-HBs 
positive, immunization decreased with increasing age (Ciorlia and Zanetta, 2005; CDC, 2008). 
 
Table (3): Sero-prevalence of HBsAg and anti-HBs markers among HCWs according to their age 










%anti-HBs      
positive 
  
      21-30   75  0 0 7    9.33٭   
      31-40   68  0 0 18    6.47٭   
      41-50   45 1 2.22 16    5.55٭   
      51-60   21 1 4.76 15      71.42٭   
      Total   209 2 0.95 56     6.79٭   
                ٭Significant correlation (P < 0.05) 
 
The seroprevalence of anti-HBs marker among HCWs according to the age is shown in (Table 3). The 
highest rate (71.42 %) was recorded among individuals in age group 51-60 years, followed by the age group 41- 
50 years with rate of (35.55 %), and the rate of (26.47 %) was noticed in the age group 31-40 years. Whereas the 
lowest rate (9.33%) was found among individuals in age group 21-30 years old. A significant importance (P< 
0.05) was registered among all age groups. However, these results indicated that the frequency of prevalent the 
anti-HBs positive in HCWs was increased with the advancing age and may reflect a frequent exposure to minute 
amounts of contaminated blood, blood products and other body fluids with development of antibodies and 
clearance of the antigen with advanced age, so this result is agreed with a previous study (Al-Mashhadani, 1998). 
Many studies was reported that the advancing age and increased working experience with higher rate of 
vaccination were significant factors which provide high rate of anti-HBs antibodies (Khan et al., 2007). 
 
The seroprevalence of HBV markers among HCWs according to their sex (Fig. 4), showed high rate of 
HBsAg maker (1.78 %) among males, whereas no evidence of this marker among females with insignificant 
differences (P > 0.05). This result agrees with previous result in Iraq (Al-Alwan et al. 1986; Al-Mashhadani, 
1998). However, epidemiologic studies of gender or ethnic populations have shown inconsistent gender 
differences among chronic hepatitis B carriers (Chironna, et al., 2003). Additionally, male HCWs are more 
involved in private medical and laboratory practice in Iraq; therefore, they have additional risk of exposure to 
   HBV infection. 










Fig.4. Seroprevalence of HBsAg and anti-HBs among HCWs according to the sex 
 
Figure 4, also shows high rate of anti-HBs (30.35 %) among males HCWs, than female (22.68 %) with 
insignificant importance (P > 0.05). These findings agree with previous results was recorded in Iraq (Al- 
Mashhadani 1998), as well as in line with many studies around the world (Al-Sohaibani, et al., 1995). 
 
3.2.1 The HBV vaccine status among HCWs workers 
       A total of 56 (26.79 %) individuals were found to be anti-HBs positive (Fig. 5), such low rate may be due to 
low number of HCWs who had been vaccinated, there was 9.1 % vaccinated HCWs who received complete 
series of 3 vaccine doses, 30.62% had incomplete vaccine doses, and 60.28 % were unvaccinated individuals, 
with significant differences (P< 0.05) among these three groups. Despite the availability of vaccination for more 
than two decades, vaccination of 100 % coverage has not yet been achieved. 
 
 
Fig. 5. Vaccine status among HCWs 
 
   The most frequently quoted reason among the unvaccinated HCWs in this study was the ignorance (lack of 
interest and lack of knowledge) about the importance of HBV prevention, as well as the another common reason 
that phobic from vaccine itself, because most of HCWs thought that plasma-derived vaccine may cause infection  
via  reactivation,  whereas  vaccine  that  used  in  Iraqi  hospitals  and  health  centers  is  genetically engineered 
vaccine (Recombinant DNA yeast-derived or mammalian cell-derived). More education or  announcement is 
needed for HCWs group about HBV vaccination. 
 
             Table (4)   shows vaccine   administration   among   HCWs   group   related   to   vaccine   doses   and 
seroprevalence rate of anti-HBs antibody among vaccinated HCWs. The highest group of them who had only 1
st 
vaccine dose was (53.0 %) with seroprevalence rate of anti-HBs was only (40.9 %) among this group with 
significant differences (P < 0.05). 
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Table (4): The effectiveness of vaccine among HCWs related to vaccine doses 











 No. % No. %  
1
st 
 44 53.0 18 40.9٭  
2
nd
 20 24.1 19 95٭  
3
rd 
 19 22.9 18 94.7٭  
Total 
vaccinated 
83 100 55 66.26٭  
٭Significant differences (P < 0.05) 
 
The second group who had received 2
nd 
vaccine doses performed (24.1%) and with significant (P < 
0.05) seroprevalence rate of anti-HBs antibody (95%), whereas the lowest rate (22.9%) of administration was 
located among those who had complete series of three doses with seroprevalence rate of anti- HBs (94.7%) 
with  significant importance (P  < 0.05). These results indicate the absence of follow up for complete 
vaccination program. However, it also indicate high effectiveness of vaccine related to the doses, since 3 series 
vaccine doses resulted in protection 98-100 % of infants and 90-95 % of teens and adults (USA / CDC, 2008; 
Bhat, et al, 2012). 
 
 Conclusions 
This study demonstrated that seroprevalence of HBsAg among normal population was lower than 
previous figures in Baghdad. It was higher among males than females. The adults had high seroprevalence of 
HBsAg and anti-HBc Total compared with infants and children. In contrast anti-HBs were high among infants 
and children. No significant importance in seroprevalence of anti-HBc Total between both sexes, while the 
seroprevalence of anti-HBs was high among males than females. As well as it demonstrated the 
seroprevalence of HBsAg among HCWs was lower than previous figures in Baghdad, and it was more 
prevalent among males than females. The prevalence of anti-HBs among HCWs increased with advanced age, 
it is higher in males than females. Low rate of complete while high rate of incomplete series vaccine doses 
among HCWs and high rate of vaccinated HCWs was located among those with high healthy education 
more than those from low levels. Seroprevalence of HBsAg  and  anti-HBc  Total  was  lower  among  
HCWs  than  normal  population,  while  anti-HBs  was  more prevalent in HCWs compared to normal 
population group. 
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